Fed. Circ. Affirms USPTO's No-Matter-What Attys' Fees Rule
Ruling against drugmaker NantKwest Inc., the panel majority said that Congress intended to include attorneys' fees when it wrote language into both the Patent Act and Lanham Act that requires appealing applicants pay "all expenses of the proceeding" regardless of the outcome.
“Given the Supreme Court’s construction of ‘expenses,’...
To view the full article, register now.